Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-ART-40374
Cell Mol Life Sci 2009 Dec 01;6623:3797-808. doi: 10.1007/s00018-009-0153-9.
Show Gene links Show Anatomy links

GABA transporter lysine 448: a key residue for tricyclic antidepressants interaction.

Cherubino F , Miszner A , Renna MD , Sangaletti R , Giovannardi S , Bossi E .


???displayArticle.abstract???
The effects of three tricyclic antidepressants (TCAs) and two serotonin selective reuptake inhibitors (SSRIs) have been studied with an electrophysiological approach on Xenopus laevis oocytes expressing the rat GABA (gamma-Aminobutyric-acid) transporter rGAT1. All tested TCAs and SSRIs inhibit the GABA-associated current in a dose-dependent way with low but comparable efficacy. The pre-steady-state and uncoupled currents appear substantially unaffected. The efficacy of desipramine, but not of the other drugs, is strongly increased in the lysine-glutamate or -aspartate mutants K448E and K448D. Comparison of I(max) and K(0.5GABA) in the absence and presence of desipramine showed that both parameters are reduced by the drug in the wild-type and in the K448E mutant. This suggests an uncompetitive inhibition, in which the drug can bind only after the substrate, an explanation in agreement with the lack of effects on the pre-steady-state and leak currents, and with the known structural data.

???displayArticle.pubmedLink??? 19756379
???displayArticle.pmcLink??? PMC11115653
???displayArticle.link??? Cell Mol Life Sci



References [+] :
Andersen, Location of the antidepressant binding site in the serotonin transporter: importance of Ser-438 in recognition of citalopram and tricyclic antidepressants. 2009, Pubmed